Blissco Receives Positive EU GMP Inspection Report
07 März 2019 - 2:00PM
Not for distribution in the U.S. or to
U.S. Newswires
Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B),
(“Blissco”) or the (“Company”) is a Canadian wellness cannabis
brand based in British Columbia, a licensed processor and producer
of premium dried cannabis and cannabis oil, and a licensed
distributor of dried cannabis products. The Company is pleased to
share it has received a positive initial European Union Good
Manufacturing Practices (“EU GMP”) report from the German Health
Authority that recently completed its four-day inspection of the
Blissco facility.
“Receiving our initial GMP Inspection Report from the German
Health Authority is a key milestone in earning our GMP
certification,” said Damian Kettlewell, Blissco CEO. “Our GMP
certification will allow us to obtain the necessary permits and
complete our first export to the rapidly growing medical cannabis
sector in Germany via our distribution partner Pharmadrug
Production GmbH. GMP certification will also open up more market
and product opportunities for Blissco, providing us with additional
opportunities to enhance shareholder value.”
Last week, Blissco presented at the Canadian Childhood
Cannabinoid Clinical Trials Workshop at Sick Kids Hospital. “The
researchers and pediatricians that we met with indicated that they
could only partner with GMP certified facilities for these kinds of
clinical trials. Their feedback added further validation that our
ongoing investment in earning this certification will help support
Blissco in establishing new strategic partnerships and ultimately
drive growth,” said Damian Kettlewell, Blissco CEO.
About Blissco Cannabis Corp.
Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) is
a Canadian wellness cannabis brand based in British Columbia and a
multi-licensed processor, cultivator, and distributor of premium
cannabis.
Blissco owns and operates an 18,000 square foot,
state-of-the-art GPP facility located in Metro Vancouver, British
Columbia with extraction, cultivation and processing rooms. Blissco
is supplying premium cannabis and small-batch Reserve whole flower
and dried flower pre-rolls to the Canadian and global marketplace
with a growing list of provincial cannabis boards and international
distribution partners.
With a license to process cannabis oil acquired in August 2018,
Blissco’s extraction lab is also in operation preparing a line of
full spectrum oils for distribution in 2019.
Learn more at blissco.com.
On Behalf of the Board of Directors BLISSCO CANNABIS CORP.
Damian Kettlewell, CEO, Founder & Chair For further information
please contact: 1 604 484-9119 investors@blissco.com Cautionary
Statements This news release contains certain forward-looking
information and forward-looking statements within the meaning of
applicable securities legislation (collectively “forward-looking
statements”). The use of any of the word “will” and similar
expressions are intended to identify forward-looking statements.
These statements involve known and unknown risks, uncertainties and
other factors that may cause actual results or events to differ
materially from those anticipated in such forward-looking
statements. Such forward-looking statements should not be unduly
relied upon. This news release contains forward-looking statements
and assumptions pertaining to the following: the ability to execute
on our strategic plans and the impact on our future operations,
capital expenditures, receipt of a cannabis oil license and a
license to sell dried cannabis and other objectives. Actual results
achieved may vary from the information provided herein as a result
of numerous known and unknown risks and uncertainties and other
factors. The Company believes the expectations reflected in those
forward-looking statements are reasonable, but no assurance can be
given that these expectations will prove to be correct. The Company
does not undertake to update these forward-looking statements,
except as required by law. The CSE has in no way passed upon the
merits of the proposed transaction and has neither approved nor
disapproved the contents of this press release.
BlissCo Cannabis (CSE:BLIS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
BlissCo Cannabis (CSE:BLIS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024